SmithRx Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
550
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$60M
- Investors
-
19
SmithRx General Information
Description
Developer of a pharmacy benefit manager platform designed to focus on transparency, efficiency, and data analytics. The company's system offers flexibility, control, and visibility of pharmacy benefits data for employer customers and partners, enabling members to benefit from the company's clinical programs, alternative sourcing, and transparent pricing to easily manage their prescription benefits and reduce overall drug spending.
Contact Information
Website
www.smithrx.comCorporate Office
- 300 Brannan Street
- Suite 601
- San Francisco, CA 94107
- United States
Corporate Office
- 300 Brannan Street
- Suite 601
- San Francisco, CA 94107
- United States
SmithRx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 23-Jan-2024 | $60M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series B) | 02-Feb-2022 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 16-Apr-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A2) | 31-Jul-2018 | Completed | Generating Revenue | |||
| 3. Debt - General | 01-May-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 11-Jan-2018 | $9M | $12M | Completed | Generating Revenue | |
| 1. Seed Round | 31-Mar-2017 | $3M | $3M | Completed | Generating Revenue |
SmithRx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 3,160,387 | $0.000100 | $0.08 | $0.97 | $0.97 | 1x | $0.97 | 3.25% |
| Series A | 6,730,467 | $0.000100 | $0.11 | $1.34 | $1.34 | 1x | $1.34 | 6.93% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SmithRx Comparisons
Industry
Financing
Details
SmithRx Competitors (25)
One of SmithRx’s 25 competitors is Truveris, a Venture Capital-Backed company based in Wilmington, DE.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Truveris | Venture Capital-Backed | Wilmington, DE | ||||
| Rightway | Venture Capital-Backed | New York, NY | ||||
| MEDecision | Formerly VC-backed | Dallas, TX | ||||
| Health Catalyst | Formerly VC-backed | South Jordan, UT | ||||
| Judi Health | Venture Capital-Backed | New York, NY |
SmithRx Signals
SmithRx Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 10X Group | Angel Group | Minority | ||
| Gaingels | Venture Capital | Minority | ||
| Venrock | Venture Capital | Minority | ||
| Four Cities Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority |
SmithRx Acquisitions (2)
SmithRx’s most recent deal was a Merger/Acquisition with WithMe Health. The deal was made on 01-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| WithMe Health | 01-Jan-2024 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| WhiteWell Rx | 10-Jan-2017 | Merger/Acquisition | Pharmaceuticals |
SmithRx FAQs
-
When was SmithRx founded?
SmithRx was founded in 2016.
-
Where is SmithRx headquartered?
SmithRx is headquartered in San Francisco, CA.
-
What is the size of SmithRx?
SmithRx has 550 total employees.
-
What industry is SmithRx in?
SmithRx’s primary industry is Other Healthcare Technology Systems.
-
Is SmithRx a private or public company?
SmithRx is a Private company.
-
What is the current valuation of SmithRx?
The current valuation of SmithRx is .
-
What is SmithRx’s current revenue?
The current revenue for SmithRx is .
-
How much funding has SmithRx raised over time?
SmithRx has raised $110M.
-
Who are SmithRx’s investors?
10X Group, Gaingels, Venrock, Four Cities Capital, and are 5 of 19 investors who have invested in SmithRx.
-
Who are SmithRx’s competitors?
Truveris, Rightway, MEDecision, Health Catalyst, and Judi Health are some of the 25 competitors of SmithRx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process